At
the core of the Saint Barnabas Health Care
System's Heart Failure
Treatment and Transplantation Program at Newark
Beth Israel Medical
Center is a team of dedicated physicians who
possess equal measures
of talent, experience and compassion.
The Program, established nearly 20 years ago,
is the largest of its
Kind in the state of New Jersey.
|
The
Left Ventricle Assist Device (LVAD) prolonged
the lifeof heart failure patient Janine
Quick who ultimately received a
life-saving transplant against extraordinary
odds. The 27-year-old mother of two received
a successful heart transplant after being
hospitalized on an LVAD for over two years.
|
And, when compared against other similar programs
in the country in terms of number of cases seen each year, we consistently
rank among the top 10.
Before the 1950s, organ transplantation belonged more to the realm of science
fiction than to medical science. By the early 70s it was considered an experimental
treatment with serious risks. Today, thanks to incredible advances in one of
medicine’s most rapidly evolving specialties, organ transplantation is
accepted as the standard and most cost effectivetreatment for organ failure over
the long term.
Newark Beth Israel’s program –New Jersey’s most experienced
heart transplantation program –has transplanted hearts into 450 patients
since its inception. Theprogram has all the components of a premier transplant
center, excelling in the critical factors laid out by The
United Networkof Organ Sharing, the nation’s organ donation and procurement
governing body, including the number of transplants performed, the graft survival
rates and the confidence instilled by the transplant team. With its long-standing
history of excellence in transplantation, Newark Beth Israel has received approval
to establish the state’s only lung transplantation service and is well-positioned
to implement an exceptional program.
Recognizing that heart and lung transplants are complex, life-altering events,
the program prides itself on delivering comprehensive support throughout the
transplant process. On all fronts – research, mechanical assist devices
and transplant – the program is advancing at an unprecedented rate and
is poised for future growth and scientific breakthroughs.
[ top ]
|
|
|
